We are live on
!
Find out more
CCMW
Cypress Capital Management (Wyoming) Portfolio holdings
AUM
$108M
1-Year Est. Return
54.47%
This Fund
S&P 500
This Quarter
Est. Return
+3.67%
1 Year Est. Return
+54.47%
3 Year Est. Return
+138.31%
5 Year Est. Return
+183.27%
10 Year Est. Return
+648.96%
AUM
$87.2M
AUM Growth
+$6.42M
(+7.9%)
Cap. Flow
+$4.56M
Cap. Flow
% of AUM
5.22%
Top 10 Holdings %
Top 10 Hldgs %
51.88%
Holding
298
New
31
Increased
42
Reduced
52
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$1.46M |
| 2 |
ARI
Apollo Commercial Real Estate
ARI
|
+$1.17M |
| 3 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
+$884K |
| 4 |
Applied Optoelectronics
AAOI
|
+$664K |
| 5 |
NVIDIA
NVDA
|
+$587K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$957K |
| 2 |
Bristol-Myers Squibb
BMY
|
+$576K |
| 3 |
WLL
Whiting Petroleum Corporation
WLL
|
+$569K |
| 4 |
SM Energy
SM
|
+$500K |
| 5 |
Rithm Capital
RITM
|
+$495K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 27.62% |
| 2 | Technology | 15.28% |
| 3 | Healthcare | 12.85% |
| 4 | Financials | 8.66% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Altria Group
MO
$122B
| $10.2M | 11.75% |
137,593
-675
| -0.5% | -$49.4K |
|
|
CELG
2
DELISTED
Celgene Corp
CELG
| $6.59M | 7.55% |
50,736
+1,030
| +2% | +$126K |
|
|
RAI
3
DELISTED
Reynolds American Inc
RAI
| $6.21M | 7.12% |
94,695
-700
| -0.7% | -$45.7K |
|
4
First Interstate BancSystem
FIBK
$3.67B
| $5.6M | 6.42% |
150,633
+6,632
| +5% | +$249K |
|
5
Apple
AAPL
$4.95T
| $4.77M | 5.46% |
132,344
+320
| +0.2% | +$11.8K |
|
|
6
NVIDIA
NVDA
$4.76T
| $3.11M | 3.57% |
860,800
+184,920
| +27% | +$587K |
|
7
Philip Morris
PM
$305B
| $2.33M | 2.67% |
19,820
-150
| -0.8% | -$17.4K |
|
|
VGR
8
DELISTED
Vector Group Ltd.
VGR
| $2.24M | 2.57% |
171,817
+11,169
| +7% | +$147K |
|
9
Schwab US Dividend Equity ETF
SCHD
$103B
| $2.1M | 2.4% |
139,530
+14,385
| +11% | +$216K |
|
10
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
| $2.06M | 2.36% |
25,946
+1,675
| +7% | +$128K |
|
11
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $2.05M | 2.35% |
52,355
+3,270
| +7% | +$127K |
|
|
12
DXC Technology
DXC
$1.68B
| $1.46M | 1.67% |
+21,993
| New | +$1.46M |
|
|
ARI
13
Apollo Commercial Real Estate
ARI
$876M
| $1.37M | 1.57% |
73,900
+62,400
| +543% | +$1.17M |
|
14
Merck
MRK
$323B
| $1.36M | 1.56% |
22,254
| – | – |
|
15
State Street Technology Select Sector SPDR ETF
XLK
$114B
| $1.26M | 1.45% |
46,100
-660
| -1% | -$18.2K |
|
|
SNR
16
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $1.2M | 1.38% |
119,700
+11,500
| +11% | +$116K |
|
17
Constellation Brands
STZ
$22.2B
| $1.19M | 1.36% |
6,123
| – | – |
|
|
ENTL
18
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $1.05M | 1.21% |
+63,540
| New | +$884K |
|
19
Starbucks
SBUX
$118B
| $953K | 1.09% |
16,340
+3,150
| +24% | +$190K |
|
|
EEP
20
DELISTED
Enbridge Energy Partners
EEP
| $917K | 1.05% |
57,300
+26,800
| +88% | +$465K |
|
21
RTX Corp
RTX
$294B
| $885K | 1.02% |
11,520
| – | – |
|
22
Verizon
VZ
$198B
| $840K | 0.96% |
18,801
-6,849
| -27% | -$319K |
|
23
Schwab US Large-Cap Growth ETF
SCHG
$58.8B
| $814K | 0.93% |
103,024
+9,120
| +10% | +$71.1K |
|
24
Nike
NKE
$62.5B
| $733K | 0.84% |
12,376
-890
| -7% | -$48K |
|
25
Johnson & Johnson
JNJ
$641B
| $731K | 0.84% |
5,522
| – | – |
|
Similar funds
GCCM
BAM
PCC
PFG
IPS
FA
HPM
SFAM
Cypress Capital Management (Wyoming)'s Q2 2017 Portfolio in Review
As of Q2 2017, Cypress Capital Management (Wyoming) held 298 positions worth $87.2M, up 7.9% from $80.8M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Cypress Capital Management (Wyoming) deployed $4.56M of net new capital in Q2 2017, opening 31 new positions and adding to 42 existing holdings. Its largest new stake was DXC Technology: 21,993 shares worth $1.46M.
By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $576K trimmed.
- Cypress Capital Management (Wyoming)'s largest Q2 2017 buy was DXC Technology: 21,993 shares worth $1.46M.
- Cypress Capital Management (Wyoming) added most to Apollo Commercial Real Estate in Q2 2017, an estimated $1.17M increase.
- Cypress Capital Management (Wyoming)'s biggest Q2 2017 reduction was Bristol-Myers Squibb, cutting an estimated $576K.
- Cypress Capital Management (Wyoming) fully exited TJX Companies in Q2 2017, selling an estimated $957K.
- Cypress Capital Management (Wyoming)'s ten largest holdings make up 52% of its $87.2M portfolio in Q2 2017.
- Cypress Capital Management (Wyoming) opened 31 new positions and closed 31 in Q2 2017.
- Cypress Capital Management (Wyoming)'s portfolio value rose 7.9% quarter-over-quarter to $87.2M.
Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2017, filed 19 Jul 2017.